Summary:
- This article discusses how gene editing technology was used to treat a baby born with a rare genetic disorder called X-linked myotubular myopathy, which causes severe muscle weakness and is often fatal in infants.
- The researchers used a gene-editing tool called CRISPR to correct the genetic mutation in the baby's cells, allowing the child to thrive and develop normally, which is a significant breakthrough in the field of genetic medicine.
- The successful treatment of this baby demonstrates the potential of gene editing to transform the lives of children with rare and devastating genetic diseases, and opens up new avenues for further research and development in this rapidly advancing field of science.